n INTRODUCTION F ibromyalgia syndrome (FS) is a rheumatic disorder characterized by chronic musculoskeletal pain throughout the body and fatigability, with no abnormal results on routine laboratory tests. The diagnosis is made on the basis of the criteria of the American College of Rheumatology (ACR). These criteria include, additionally: pain upon digital palpation in at least 11 out of 18 tender points (1) and a variety of extra-skeletal symptoms, including sleep disorders, asthenia, cognitive alterations, gastrointestinal problems, anxiety, depression, migraine, paresthesia, etc. (2) . The most widely used framework for explaining and understanding FS is the biopsychosocial model (3) . According to this model, the pain experience is the result of a complex interaction of biological, environmental, social, cultural, racial, cognitive, and behavioral variables (4) . Adopting the biopsychosocial model, a number of studies have focused on the psychological factors involved in the onset and development of FS. Findings indicate that FS patients, compared with the general population, have higher levels of anxiety and depression and increased comorbidity with mood disorders (5), which are likely to maintain and augment FS symptoms, thus lowering the quality of life (6) . Furthermore, in a previous study of ours (7) , FS patients were shown to have a different psychological profile from healthy subjects, with higher worry and need for control. Based on evidence from the literature and our clinical interest, in the present study we focused on the psychological variables of anxiety, depression, worry and angry rumination which are involved in FS. By definition, worry and rumination are cognitive processes characterized by thinking in an abstract and repetitive fashion, with the focusing of attention on negative feelings and thoughts, and their consequences. In par- 
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ticular, worry involves thoughts about the future (8) and is activated to anticipate or prevent events with an uncertain outcome, while rumination includes a greater focus on one's negative feelings, in order to understand their causes (9) .
In an attempt to describe the cognitive profile of FS patients and suggest directions for cognitive-behavioral therapy to use with these patients, the present study compared FS patients, patients with other chronic pain syndromes (CP), and healthy subjects (HS) in relation to the above-mentioned psychological variables. Furthermore, the associations between these variables were investigated in the FS group.
n MATERIALS AND METHODS

Participants
Thirty patients (27 women, mean age 54±12 years) with fibromyalgia diagnosed according to the 1990 ACR criteria (1, 2), 30 patients (22 women, mean age 59±13 years) with CP, specifically osteoporosis and osteoarthritis, and 30 HS (matched for age and gender to the patient groups) participated in the study. Osteoporosis patients presented localized chronic pain in the back or lumbar spine from vertebral fracture (defined with the Genant semi-quantitative method); osteoarthritis patients presented localized chronic pain in affected areas. All participants were recruited in the cities of Viareggio and Forte dei Marmi (Italy), between April and July 2013. Both the FS and CP groups were recruited from the Operative Unit of Rheumatology of USL 12 Versilia. All participants gave their informed consent to participation in the study.
Measurements and procedure
Participants completed an individually administered battery of self-report measurements including: (14) to assess the severity of depression in adults and adolescents aged 13 and above. The BDI-I includes 21 items. The Italian version by Scilligo (15) was used. 5. Anger Rumination Scale (ARS) (16) to assess the tendency to ruminate about anger, including thoughts of revenge, angry memories, and understanding of causes. The ARS consists of 14 items. The Italian version was used in the present study.
n RESULTS Table II .
n DISCUSSION AND CONCLUSIONS
Fibromyalgia is a syndrome characterized by chronic, diffuse musculoskeletal pain, and by numerous extra-skeletal manifestations. The psychological factors involved in the onset and evolution of this syndrome have been the object of growing interest in recent years (4) . In accordance with the literature and with a previous study of ours (7), findings from the present study suggest that FS patients have a different psychological profile compared to patients with other chronic pain conditions and to healthy individuals. Indeed, FS patients showed higher levels of anxiety than both CP patients and HS, and reported higher depression than HS. It is noteworthy that, while FS and CP showed higher depression than HS, the CP group also presented higher depression compared to the FS. This interesting finding deserves further investigation. A novel finding of the present study was that FS patients showed higher levels of worry and angry rumination than both CP patients and HS. While higher levels of worry in FS patients compared to healthy controls had been also found in our previous study (7), findings on angry rumination are novel. To the best of our knowledge, this was the first study to investigate angry rumination in FS. Altogether, findings from this study seem to suggest that FS patients may use worry and rumination as dysfunctional strategies to cope with negative emotions, with con- 
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sequent negative effects on self-regulation and emotional well-being. We wish to emphasize that our findings are preliminary and need replication. Replications of these findings would add to our understanding of the psychological profile of patients with chronic rheumatic pain syndromes, and might have important implications for developing a tailored CBT protocol for pain management in FS patients. This might include different treatment modules focused on anxiety, worry, and angry rumination, and aim at an improvement of the patient's ability to cope with his or her painful emotional experiences. Even if literature on fibromyalgia indicates no specific interventions for the treatment of worry and angry rumination, the relatively new approach of metacognitive therapy (MCT, 17) could be used successfully. This approach, initially developed to treat general anxiety and depression (18) , has been reported to have effective outcomes also for worry and angry rumination (19, 20) . In particular, patients are helped to develop new ways for controlling attention and for relating to negative thoughts and beliefs by modifying their metacognitive beliefs, which give rise to unhelpful thinking patterns. In addition, our research group is working on CBT group-therapy interventions for worry and angry rumination in fibromyalgic patients, which seems to have potential outcomes. This very new integrated approach is based on psychoeducation, mindfulness, and problem solving training. 
